Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,284 | 103 | 99.4% |
| Education | $13.24 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $357.10 | 12 | $0 (2021) |
| ABBVIE INC. | $298.81 | 14 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $238.10 | 10 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $201.95 | 10 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $195.73 | 15 | $0 (2022) |
| Amgen Inc. | $158.38 | 5 | $0 (2020) |
| UCB, Inc. | $134.15 | 4 | $0 (2018) |
| Biogen, Inc. | $112.75 | 5 | $0 (2021) |
| US WorldMeds, LLC | $73.43 | 3 | $0 (2018) |
| Adamas Pharmaceuticals, Inc. | $58.52 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $29.50 | 1 | Neurocrine Biosciences, Inc. ($29.50) |
| 2022 | $223.51 | 11 | ABBVIE INC. ($100.42) |
| 2021 | $374.88 | 18 | AbbVie Inc. ($131.64) |
| 2020 | $201.49 | 9 | Novartis Pharmaceuticals Corporation ($43.45) |
| 2019 | $532.50 | 21 | Teva Pharmaceuticals USA, Inc. ($180.84) |
| 2018 | $310.04 | 13 | Teva Pharmaceuticals USA, Inc. ($77.68) |
| 2017 | $624.96 | 31 | Avanir Pharmaceuticals, Inc. ($145.98) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/26/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Neuropsychiatry | ||||||
| 10/20/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: PRIMARY CARE | ||||||
| 07/21/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Rare Disease | ||||||
| 06/23/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Genetic Disease | ||||||
| 05/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/31/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $13.24 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/31/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/17/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/14/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: NEUROLOGY | ||||||
| 11/10/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Immunology | ||||||
| 10/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: PD | ||||||
| 09/23/2021 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 09/15/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Immunology | ||||||
| 08/04/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Immunology | ||||||
| 06/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Central Nervous System | ||||||
| 05/19/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Immunology | ||||||
| 04/21/2021 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $19.80 | General |
| Category: NEUROLOGY | ||||||
| 03/24/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 108 | 183 | $22,090 | $12,764 |
| 2022 | 2 | 102 | 177 | $18,458 | $13,145 |
| 2021 | 2 | 124 | 217 | $23,216 | $15,843 |
| 2020 | 2 | 119 | 177 | $18,640 | $11,662 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 159 | $19,690 | $10,981 | 55.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 12 | 24 | $2,400 | $1,783 | 74.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 141 | $14,858 | $10,305 | 69.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 18 | 36 | $3,600 | $2,840 | 78.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 176 | $19,116 | $12,719 | 66.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 20 | 41 | $4,100 | $3,124 | 76.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 133 | $14,240 | $8,499 | 59.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 22 | 44 | $4,400 | $3,164 | 71.9% |
About Dr. Arthur Kowell, M.D
Dr. Arthur Kowell, M.D is a Specialist healthcare provider based in Encino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700884905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Kowell, M.D has received a total of $2,297 in payments from pharmaceutical and medical device companies, with $29.50 received in 2023. These payments were reported across 104 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,284).
As a Medicare-enrolled provider, Kowell has provided services to 453 Medicare beneficiaries, totaling 754 services with total Medicare billing of $53,414. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Neurology
- Location Encino, CA
- Active Since 07/12/2005
- Last Updated 05/24/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1700884905
Products in Payments
- NUEDEXTA (Drug) $221.63
- NUPLAZID (Drug) $195.73
- Aimovig (Biological) $158.38
- UBRELVY (Drug) $127.99
- AUSTEDO (Drug) $124.62
- Soliris (Drug) $115.67
- QULIPTA (Drug) $104.07
- COPAXONE (Drug) $100.11
- Briviact (Drug) $98.74
- TECFIDERA (Drug) $83.74
- AJOVY (Biological) $76.15
- Xadago (Drug) $73.43
- SOLIRIS (Drug) $68.81
- GOCOVRI (Drug) $58.52
- AJOVY (Drug) $56.22
- ACTIVA (Device) $47.33
- Duopa (Drug) $45.97
- NURTEC ODT (Drug) $45.83
- Neupro (Drug) $35.41
- NAMZARIC (Drug) $32.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Encino
Dr. David Kayne, M.d, M.D
Specialist — Payments: $1.1M
Dr. John Joseph, M.d, M.D
Specialist — Payments: $458,108
Dr. Douglas Sears, M.d, M.D
Specialist — Payments: $20,325
Dr. Peyman Ghasri, M.d, M.D
Specialist — Payments: $16,849
Dr. Michael Hollander, M.d, M.D
Specialist — Payments: $3,057
Helene Rosenzweig, M.d, M.D
Specialist — Payments: $2,388